Kaiser Permanente Ventures is the venture capital arm of Kaiser Permanente, focused on investing in the healthcare sector. Established in 1997 and based in Oakland, California, the firm primarily targets companies involved in medical devices, therapeutics, diagnostics, drug delivery, healthcare services, pharmaceuticals, biotechnology, and health information technology. Kaiser Permanente Ventures seeks direct investments in companies at various stages, from Series A financing onward, and also invests in venture capital funds through fund of funds. The firm typically invests between $0.5 million and $12 million in U.S.-based companies that demonstrate significant market potential, generally exceeding $500 million. Kaiser Permanente Ventures aims to collaborate with other healthcare-focused venture capital investors to enhance its investment impact.
Senior Vice President and Chief Equity, Inclusion and Diversity Office
148 past transactions
FACETS
Grant in 2025
FACETS is a Community Development Center that provide meals to individuals and families experiencing homelessness and food insecurity.
Fusion Partnerships
Grant in 2025
Fusion Partnerships is an organization that promotes joint action for social change and community development.
Innovaccer
Series F in 2025
Innovaccer Inc. develops analytical and data science applications primarily for the healthcare sector, while also serving financial services, manufacturing, retail, and academic research organizations. The company offers a comprehensive Healthcare Intelligence Cloud, which aggregates and analyzes patient data from various sources, including electronic health records and medical devices. This platform enhances patient care and operational efficiency by providing tools for risk adjustment, population health management, and care coordination. Key solutions include Datashop, which features modules for patient insights, economic market analysis, and healthcare trend datasets, as well as a Clinical Documentation Improvement solution to enhance documentation integrity. Innovaccer's offerings also include care navigation, billing, and claims processing tools to streamline operations and improve patient outcomes. The company has established partnerships to further its impact and operates globally from its headquarters in Noida, India, with an office in Palo Alto, California. Founded in 2012, Innovaccer remains committed to transforming healthcare delivery through its innovative technology platform.
Black Directors Health Equity Agenda
Grant in 2024
Black Directors Health Equity Agenda works for the welfare of the Black people and other communities.
Clarium
Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.
Q Bio
Venture Round in 2024
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Habitat Health
Venture Round in 2024
Habitat Health provides health and social care to older persons with medical services.
Vesta Healthcare
Venture Round in 2024
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.
Abridge
Series C in 2024
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.
Abridge
Series B in 2023
Abridge Inc. is a healthcare technology company founded in September 1999, focused on enhancing communication in medical settings through innovative tools. The company utilizes generative AI to automate the transcription and summarization of patient-clinician conversations, converting these interactions into structured clinical notes in real-time. This platform integrates seamlessly with Electronic Health Record (EHR) systems, significantly reducing the need for manual note-taking. By generating clear and understandable summaries, Abridge improves patient comprehension of medical discussions and ensures that relevant documentation is accurately recorded in patient files. Additionally, the company emphasizes data security and patient privacy, adhering to healthcare regulations while providing a customizable interface that caters to individual patient needs.
Gynesonics
Venture Round in 2023
Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.
Healthcare Foundation Northern Sonoma County
Grant in 2023
Healthcare Foundation is a healthcare organization that provides patients with specialty surgical services.
Georgia Primary Care Association
Grant in 2023
Georgia Primary Care Association provides PCMH learning community, clinical quality program, family planning, and data center services.
Everytable
Series C in 2023
Everytable is a company focused on providing nutritious and affordable meals through grab-and-go locations. Its mission is to transform the food system to ensure that fresh, healthy food is accessible to everyone, regardless of their background. By operating a tech-driven casual restaurant platform, Everytable offers made-from-scratch meals at lower prices, achieved by streamlining traditional restaurant costs. This approach enables consumers to conveniently order wholesome food online, promoting greater access to healthy dining options in various communities.
DexCare
Series C in 2023
DexCare is a Seattle-based provider of a platform-as-a-service designed to optimize health system capacity and demand across various lines of care. Established in 2021, the company offers a solution that transforms traditional patient-to-provider relationships into a scalable digital experience. This platform enhances patient access to the appropriate care settings, enabling healthcare institutions to attract new patients, boost revenue, and improve overall satisfaction. Additionally, DexCare's approach leads to significant cost savings while ensuring that patients receive timely and effective care.
NOCD
Series B in 2023
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities.
Born This Way Foundation
Grant in 2023
Born This Way Foundation they supports people and works with them to build an impact through programming, youth-led conversations, and strategic, cross-sectoral partnerships..
Validic
Venture Round in 2022
Validic, Inc. is a technology company that provides a cloud-based platform for collecting and managing mobile health data from various Internet-enabled health applications and devices. Founded in 2010 and based in Durham, North Carolina, Validic connects healthcare providers with patient-recorded data through its solutions, including Validic Solution, Validic Connect, and Validic Mobile. The platform integrates data from over 400 clinical and consumer devices, enabling wellness companies, healthcare providers, pharmaceuticals, and health plans to access and utilize actionable health information. By streamlining the collection and visualization of personal health data, Validic aims to enhance the quality of care and improve health outcomes for individuals.
NorthOne
Series B in 2022
NorthOne Inc. provides digital banking solutions tailored for small businesses, startups, and freelancers. Founded in 2016 and headquartered in Toronto, Canada, with additional offices in New York and Boston, the company offers a mobile-first banking app that integrates various financial tools in a single platform. Users can manage their finances through features such as automated tax, payroll, and rent envelopes, and the ability to make deposits from anywhere. The app is accessible on iOS, Android, and desktop, ensuring a seamless banking experience while allowing businesses to focus more on their operations and community engagement.
Kate Farms
Series C in 2022
Kate Farms, Inc. is a company that specializes in producing vegan meal replacement shakes and tube feeding solutions for both adults and children. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company focuses on developing plant-based formulas that are easy to digest and made from organic ingredients. These products are designed to provide nutrition without common allergens or synthetic additives, making them suitable for individuals with various dietary restrictions and medical conditions. Kate Farms' offerings are available through both prescription and over-the-counter channels, and the company serves a wide range of patients, from those with severe chronic diseases to those with less serious health issues. Its products are distributed through a network of retail stores across the United States and online.
Incredible Health
Series B in 2022
Incredible Health, Inc. operates a technology-driven platform that connects healthcare providers with nursing professionals to address staffing challenges. Founded in 2015 and based in San Francisco, the company offers a subscription-based job portal that facilitates the recruitment process for medical candidates. This platform allows users, including fresh graduates, unemployed medical staff, and practicing healthcare professionals, to filter job searches, receive alerts, apply for interviews, and access career advice from recruitment experts. Utilizing AI technology, Incredible Health custom matches healthcare organizations with qualified nurses for hard-to-fill positions, aiming to enhance the hiring experience and improve the lives of healthcare professionals.
Everytable
Series C in 2022
Everytable is a company focused on providing nutritious and affordable meals through grab-and-go locations. Its mission is to transform the food system to ensure that fresh, healthy food is accessible to everyone, regardless of their background. By operating a tech-driven casual restaurant platform, Everytable offers made-from-scratch meals at lower prices, achieved by streamlining traditional restaurant costs. This approach enables consumers to conveniently order wholesome food online, promoting greater access to healthy dining options in various communities.
Magnetic Insight
Series B in 2022
Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.
Ordr
Series C in 2022
Ordr, Inc. is a cybersecurity company that specializes in securing Internet of Things (IoT) devices. Founded in 2015 and based in Santa Clara, California, Ordr offers a platform that utilizes machine learning and deep packet inspection to identify and monitor every connected device within an enterprise. The company's Systems Control Engine, a software-as-a-service solution, autonomously classifies devices, regulates network traffic, and enforces access policies to enhance security. Ordr serves various industries, including healthcare, manufacturing, retail, public venues, and logistics, providing real-time asset inventory and addressing risks and compliance needs. Organizations around the world rely on Ordr's technology to safeguard their networks and streamline IT operations.
Tidelift
Series C in 2022
Tidelift specializes in enhancing the management and security of open-source software for professional developers. By offering a subscription service that partners directly with project maintainers, Tidelift provides a reliable source of proactively managed open-source components. The company's offerings include assurances related to security, licensing, and ongoing maintenance, which help businesses improve the overall quality of their software. This approach not only supports the sustainability of open-source projects but also accelerates the development of innovative software solutions.
Zepto
Series D in 2022
Zepto is an e-grocery company that specializes in the rapid delivery of daily essentials and grocery items directly to customers' doorsteps. Utilizing hyperlocal dark stores, Zepto stocks a variety of fresh produce, snack foods, and electronics, which can be conveniently ordered through its app or website. The company aims to provide a seamless online shopping experience, catering to the needs of customers seeking quick access to grocery products. By focusing on timely delivery, Zepto serves various sectors, including retail, food and beverage, and logistics.
IntelyCare
Series C in 2022
IntelyCare, Inc. is a healthcare staffing company based in Quincy, Massachusetts, founded in 2014. It provides an on-demand staffing platform that connects nursing professionals with post-acute healthcare facilities, enabling them to optimize staffing levels and manage workforce demands effectively. The platform allows nurses and nursing assistants to create their own schedules and select shifts that suit them, fostering a flexible work environment. Utilizing advanced data science and artificial intelligence, IntelyCare automates scheduling and improves the efficiency of filling nursing shifts, achieving rates three times the industry average. The company serves a variety of clients, including home care agencies, assisted living facilities, long-term care establishments, and rehabilitation hospitals, ultimately aiming to reduce burnout among nursing staff and enhance overall productivity. IntelyCare operates as a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC.
Osso VR
Series C in 2022
Osso VR is a virtual reality training platform that specializes in surgical and medical device education. It provides an immersive training environment where medical professionals, including residents and experienced surgeons, can engage in realistic simulations of various procedures. The platform emphasizes hands-on experiences and realistic interactions, allowing users to familiarize themselves with the latest instruments and surgical robotics. By offering advanced training solutions, Osso VR aims to enhance the skills and proficiency of medical personnel, ultimately improving patient outcomes in surgical settings.
Anyroad
Series B in 2022
AnyRoad Inc. operates a cloud-based platform that connects tourism customers with professional tour guides, facilitating the booking and management of various tours and experiences. Founded in 2012 and headquartered in San Francisco, California, the company serves multiple global locations, including Rio de Janeiro, San Francisco, New York, London, Tokyo, and Israel. AnyRoad specializes in experiential marketing, enabling businesses to enhance their events, tours, and other branded experiences to foster consumer loyalty and improve return on investment. The platform integrates with existing customer relationship management and point-of-sale systems, allowing brands to measure the impact of experiences on consumer perceptions and revenue growth, thereby optimizing their marketing strategies.
Secureframe
Series B in 2022
Secureframe, Inc., established in 2020 and headquartered in San Francisco, California, offers a compliance automation platform designed to assist organizations in achieving and maintaining compliance with various security and privacy standards. The platform automates compliance audits and facilitates ongoing monitoring, helping businesses manage their data securely and protect client privacy. Secureframe serves a diverse clientele, including fast-growing companies such as AngelList, Ramp, Remote, and Coda, by simplifying their compliance processes with global standards like SOC 2, ISO 27001, PCI DSS, HIPAA, and GDPR. This empowers businesses to build trust with customers through efficient and effective compliance management.
Big Health
Series C in 2022
Big Health is a digital therapeutics company based in London, United Kingdom, specializing in sleep improvement solutions. It offers a digital healthcare portal that provides fully automated and personalized behavioral programs aimed at addressing mental health issues, particularly sleep disorders. The flagship application, Sleepio, utilizes Cognitive Behavioral Therapy techniques to tailor interventions to individual users' needs, helping them effectively manage and overcome their sleep-related challenges. By consulting with medical professionals, Big Health ensures that its programs are both evidence-based and user-friendly, promoting better sleep and overall mental well-being.
DexCare
Series B in 2022
DexCare is a Seattle-based provider of a platform-as-a-service designed to optimize health system capacity and demand across various lines of care. Established in 2021, the company offers a solution that transforms traditional patient-to-provider relationships into a scalable digital experience. This platform enhances patient access to the appropriate care settings, enabling healthcare institutions to attract new patients, boost revenue, and improve overall satisfaction. Additionally, DexCare's approach leads to significant cost savings while ensuring that patients receive timely and effective care.
Medically Home
Venture Round in 2022
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.
NOCD
Series B in 2021
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities.
Genome Medical
Series C in 2021
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.
Abogen Biosciences
Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
OM1
Series D in 2021
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
Spinny
Series D in 2021
Spinny is a technology-driven platform that facilitates the buying and selling of used cars, aiming to create a trustworthy and straightforward experience in the Indian automotive market. Established in 2015 and headquartered in Gurgaon, Haryana, Spinny operates on a full-stack business model that emphasizes value, transparency, and simplicity for its customers. The platform offers a curated selection of pre-owned vehicles, complete with detailed information, and provides features such as test drives and a five-day money-back guarantee. This approach allows car owners to easily list their vehicles while potential buyers benefit from a clear and uncomplicated purchasing process. Spinny's mission is to help customers find cars that align with their aspirations.
Osso VR
Series B in 2021
Osso VR is a virtual reality training platform that specializes in surgical and medical device education. It provides an immersive training environment where medical professionals, including residents and experienced surgeons, can engage in realistic simulations of various procedures. The platform emphasizes hands-on experiences and realistic interactions, allowing users to familiarize themselves with the latest instruments and surgical robotics. By offering advanced training solutions, Osso VR aims to enhance the skills and proficiency of medical personnel, ultimately improving patient outcomes in surgical settings.
Protenus
Series D in 2021
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.
PathAI
Series C in 2021
PathAI, Inc. is a company that develops artificial intelligence-based technology solutions aimed at enhancing the accuracy and efficiency of pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI's platform utilizes machine and deep learning techniques to process large datasets, enabling pathologists to diagnose cancer and other conditions rapidly and accurately. The technology not only assists in making precise diagnoses but also identifies patients who may benefit from innovative therapies, thereby facilitating personalized medicine. PathAI addresses complex challenges in pathology for both the research and pharmaceutical industries, providing reliable and scalable solutions.
Medically Home
Corporate Round in 2021
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.
Recover Together
Series C in 2021
Recover Together, Inc. operates private clinics that specialize in treating opioid addiction through a comprehensive approach that includes medication-assisted treatment and therapy. Founded in 2014 and headquartered in Manchester, New Hampshire, the company offers services across multiple states, including California, Indiana, Maine, Michigan, West Virginia, and North Carolina. Its treatment model combines the use of Suboxone (buprenorphine) with weekly group therapy sessions, allowing patients to engage in a supportive community while working toward their recovery goals. The organization is committed to making addiction treatment respectful, accessible, and affordable, empowering individuals to regain control of their lives and improve their overall quality of life.
Vesta Healthcare
Venture Round in 2021
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.
DexCare
Series A in 2021
DexCare is a Seattle-based provider of a platform-as-a-service designed to optimize health system capacity and demand across various lines of care. Established in 2021, the company offers a solution that transforms traditional patient-to-provider relationships into a scalable digital experience. This platform enhances patient access to the appropriate care settings, enabling healthcare institutions to attract new patients, boost revenue, and improve overall satisfaction. Additionally, DexCare's approach leads to significant cost savings while ensuring that patients receive timely and effective care.
Evidation Health
Series E in 2021
Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.
Nuvolo
Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.
New Amsterdam Pharma
Series A in 2021
NewAmsterdam Pharma is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cardio-metabolic diseases. The company aims to enhance patient care for individuals with metabolic disorders by addressing the shortcomings of currently available treatments. Its leading product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor designed to effectively lower LDL cholesterol levels while potentially overcoming the limitations associated with existing therapies.
dMed
Series C in 2020
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
Everytable
Series B in 2020
Everytable is a company focused on providing nutritious and affordable meals through grab-and-go locations. Its mission is to transform the food system to ensure that fresh, healthy food is accessible to everyone, regardless of their background. By operating a tech-driven casual restaurant platform, Everytable offers made-from-scratch meals at lower prices, achieved by streamlining traditional restaurant costs. This approach enables consumers to conveniently order wholesome food online, promoting greater access to healthy dining options in various communities.
Kate Farms
Series B in 2020
Kate Farms, Inc. is a company that specializes in producing vegan meal replacement shakes and tube feeding solutions for both adults and children. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company focuses on developing plant-based formulas that are easy to digest and made from organic ingredients. These products are designed to provide nutrition without common allergens or synthetic additives, making them suitable for individuals with various dietary restrictions and medical conditions. Kate Farms' offerings are available through both prescription and over-the-counter channels, and the company serves a wide range of patients, from those with severe chronic diseases to those with less serious health issues. Its products are distributed through a network of retail stores across the United States and online.
Osso VR
Series A in 2020
Osso VR is a virtual reality training platform that specializes in surgical and medical device education. It provides an immersive training environment where medical professionals, including residents and experienced surgeons, can engage in realistic simulations of various procedures. The platform emphasizes hands-on experiences and realistic interactions, allowing users to familiarize themselves with the latest instruments and surgical robotics. By offering advanced training solutions, Osso VR aims to enhance the skills and proficiency of medical personnel, ultimately improving patient outcomes in surgical settings.
Truepill
Series C in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.
Ginger
Series D in 2020
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
Genome Medical
Series B in 2020
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.
Cedar
Series C in 2020
Cedar is a patient payment and engagement platform designed for hospitals, health systems, and medical groups to enhance the overall patient experience. Founded in 2016 and headquartered in New York, the platform utilizes advanced data science to streamline and personalize the billing process. By consolidating billing information from various caregivers, Cedar provides clear invoices that detail patient obligations while offering user-friendly click-to-pay options. This modern approach not only simplifies the payment experience but also supports healthcare providers in improving their billing operations and fostering better patient engagement.
Big Health
Series B in 2020
Big Health is a digital therapeutics company based in London, United Kingdom, specializing in sleep improvement solutions. It offers a digital healthcare portal that provides fully automated and personalized behavioral programs aimed at addressing mental health issues, particularly sleep disorders. The flagship application, Sleepio, utilizes Cognitive Behavioral Therapy techniques to tailor interventions to individual users' needs, helping them effectively manage and overcome their sleep-related challenges. By consulting with medical professionals, Big Health ensures that its programs are both evidence-based and user-friendly, promoting better sleep and overall mental well-being.
Orca Bio
Series D in 2020
Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients suffering from malignant and autoimmune diseases. The company has developed proprietary technologies aimed at replacing diseased blood and immune systems with healthy cells. Orca Bio specializes in the research and development of innovative cell therapies that enhance the effectiveness of bone marrow transplants, creating a life-saving platform for various medical conditions. With a team of leading experts and technologists, Orca Bio is committed to advancing its pipeline of therapies to improve patient outcomes and transform healthcare practices.
Ordr
Series B in 2020
Ordr, Inc. is a cybersecurity company that specializes in securing Internet of Things (IoT) devices. Founded in 2015 and based in Santa Clara, California, Ordr offers a platform that utilizes machine learning and deep packet inspection to identify and monitor every connected device within an enterprise. The company's Systems Control Engine, a software-as-a-service solution, autonomously classifies devices, regulates network traffic, and enforces access policies to enhance security. Ordr serves various industries, including healthcare, manufacturing, retail, public venues, and logistics, providing real-time asset inventory and addressing risks and compliance needs. Organizations around the world rely on Ordr's technology to safeguard their networks and streamline IT operations.
IntelyCare
Series B in 2020
IntelyCare, Inc. is a healthcare staffing company based in Quincy, Massachusetts, founded in 2014. It provides an on-demand staffing platform that connects nursing professionals with post-acute healthcare facilities, enabling them to optimize staffing levels and manage workforce demands effectively. The platform allows nurses and nursing assistants to create their own schedules and select shifts that suit them, fostering a flexible work environment. Utilizing advanced data science and artificial intelligence, IntelyCare automates scheduling and improves the efficiency of filling nursing shifts, achieving rates three times the industry average. The company serves a variety of clients, including home care agencies, assisted living facilities, long-term care establishments, and rehabilitation hospitals, ultimately aiming to reduce burnout among nursing staff and enhance overall productivity. IntelyCare operates as a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC.
Vesta Healthcare
Series A in 2020
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.
Ginger
Series C in 2019
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
Protenus
Series C in 2019
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.
Polarity
Series A in 2019
Polarity is a computer software company focused on enhancing collaboration and decision-making in information technology. It offers a memory augmentation platform that analyzes the content displayed on users' computer screens, providing real-time access to relevant information without disrupting their existing workflow. The platform also integrates data from external sources, enabling organizations to make more informed and timely decisions through on-screen overlays. Polarity aims to streamline the process of information retrieval and improve efficiency across teams and workflows.
Freenome
Series B in 2019
Freenome, Inc. is a biotechnology company based in South San Francisco, California, founded in 2014. It specializes in developing artificial intelligence-driven genomic solutions for the early detection of cancer. The company focuses on creating simple, non-invasive blood tests that can identify early-stage cancer and assist in treatment selection, thus enabling proactive disease management. Freenome’s multi-omics platform employs proprietary algorithms to enhance disease screening processes, aiming to facilitate timely interventions and improve treatment effectiveness. In addition to its diagnostic products, Freenome also offers clinical research services to support its mission of transforming cancer management through systematic early detection.
Nuvolo
Series B in 2019
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.
Omada
Series D in 2019
Omada Health, Inc. is a digital healthcare company that creates and implements online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health focuses on helping employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the unique needs of participants, incorporating professional health coaching, connected health devices, and real-time data to foster sustainable lifestyle changes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program, delivering clinically effective solutions that empower individuals to take charge of their health and achieve their wellness goals.
Health Catalyst
Debt Financing in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Health Catalyst
Series F in 2019
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Vesta Healthcare
Series A in 2018
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.
Multisensor Diagnostics
Seed Round in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.
CareAcademy
Seed Round in 2018
CareAcademy specializes in providing online training for senior care professionals, aiming to enhance the quality of service delivered to older adults. The platform offers a comprehensive range of courses, including topics such as infection control, nutrition, meal preparation, dementia care, fall prevention, and safe transfers. This educational resource empowers over 250,000 direct care workers to advance their skills and professional development. Additionally, CareAcademy features an advanced reporting, training, and compliance management dashboard, making it a scalable training solution that helps home care businesses operate more efficiently and effectively.
Protenus
Series B in 2018
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.
Genome Medical
Series A in 2018
Genome Medical, Inc. is a company based in South San Francisco, California, that specializes in genetic consultation and medical consulting services. Established in 2016, it operates a platform that connects individuals and healthcare providers to genetic specialists through its Genome Care Delivery technology. The company offers expert virtual genetic care across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By providing genetic assessments and personalized clinical action plans, Genome Medical enables patients to understand their genetic risks, make informed treatment decisions, and enhance overall health outcomes. The company aims to facilitate the integration of genomic medicine into everyday healthcare, assisting both patients and practitioners in navigating the complexities of genetic testing and its implications for disease diagnosis and management.
Collective Medical
Series A in 2017
Collective Medical operates a collaborative care management platform designed to enhance patient outcomes by addressing communication gaps in healthcare. Based in Salt Lake City, the company connects a nationwide network that includes every national health plan, hundreds of hospitals, and tens of thousands of healthcare providers. Its system-agnostic platform leverages real-time data, risk analytics, and shared care guidelines to identify at-risk and complex patients. By facilitating actionable collaboration among care teams, Collective Medical aims to reduce emergency department visits and avoidable readmissions for high-risk patients. The platform improves coordination across diverse care teams, streamlines transitions of care, and supports better decision-making, ultimately ensuring patients receive appropriate care in the right setting.
Protenus
Series A in 2017
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.
Chrono Therapeutics
Series B in 2016
Chrono Therapeutics Inc. is a pharmaceutical company based in Hayward, California, specializing in digital transdermal drug delivery systems. Founded in 2003, the company has developed SmartStop, a digital nicotine replacement therapy that incorporates a wearable device. This innovative solution allows for programmable delivery of nicotine, adjusting timing and dosage to effectively manage withdrawal symptoms and peak addiction triggers. By combining this transdermal therapy with real-time behavioral support, Chrono Therapeutics aims to enhance smoking cessation efforts and improve clinical outcomes for users. The leadership team brings extensive experience in product development, research and development, and a deep understanding of the smoking cessation market, positioning the company to play a significant role in addressing the smoking epidemic.
Big Health
Series B in 2016
Big Health is a digital therapeutics company based in London, United Kingdom, specializing in sleep improvement solutions. It offers a digital healthcare portal that provides fully automated and personalized behavioral programs aimed at addressing mental health issues, particularly sleep disorders. The flagship application, Sleepio, utilizes Cognitive Behavioral Therapy techniques to tailor interventions to individual users' needs, helping them effectively manage and overcome their sleep-related challenges. By consulting with medical professionals, Big Health ensures that its programs are both evidence-based and user-friendly, promoting better sleep and overall mental well-being.
Torax Medical
Series E in 2016
Torax Medical, Inc. is a clinical-stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters to treat various digestive diseases. Its primary offerings include LINX, a reflux management system designed for patients with gastroesophageal reflux disease (GERD), and FENIX, a continence restoration system for fecal incontinence. Utilizing specialized magnets, these devices facilitate minimally invasive procedures to address these conditions. Torax Medical operates in both the European and U.S. markets and is a subsidiary of Ethicon, Inc.
Bluesight
Series C in 2016
Bluesight addresses supply chain inefficiencies in healthcare by offering actionable analytics throughout the medication lifecycle. The company has developed a hospital inventory management platform that automates pharmacy kit processing and medication tracking, aiming to streamline the often cumbersome and error-prone manual processes associated with medication handling. By implementing automation technology, Bluesight enhances operational efficiency, improves patient safety, and increases medication visibility within hospitals. Through its suite of Medication Intelligence solutions, the company simplifies the complexities of medication management, providing healthcare professionals with the tools needed for better decision-making and risk reduction.
CareGuardian
Series B in 2016
CareGuardian, founded in 2014, specializes in providing caregiver services for elderly patients, emphasizing the importance of both professional and family caregivers in delivering exceptional support for older adults. The company offers a user-centric technology platform developed in-house, which connects caregivers, clinicians, and care managers. This innovative approach aims to empower caregivers and ensure that seniors can age safely and remain engaged with their communities while receiving the necessary care at home. By focusing on training and support, CareGuardian seeks to enhance the visibility and recognition of caregivers, fostering a more effective caregiving environment.
Vidyo
Series E in 2015
We’re video-enabling the world. Recognized in the Gartner Magic Quadrant as a leader and a visionary, Vidyo is used by organizations like Google, CERN, Etsy, Philips, Alibaba, Kaiser, DISA and others. We are tackling a huge challenge: to ensure that the world can take advantage of the endless benefits of video chat by making it better than any other form of communication, whether you are in the office - or far out in the field under challenging bandwidth and wifi conditions. Vidyo makes it easy to embed the most beautiful, resilient and immersive multiparty video chat into any application, on any connected device. In healthcare, banking, IoT, customer engagement, enterprise collaboration, government, field services and more, video chat is revolutionizing - while simplifying - how we communicate. We envision a future in which hospitals, banks, universities, police stations, data centers, manufacturing facilities and all places in between see elegant video chat as the sustainable and intuitive way for humans to better connect with one another - making us more productive while saving tons of time and resources. From Silicon Valley to New York, Europe, Asia-Pacific and beyond, Vidyo is one of the most diverse teams in tech, with hundreds of gifted employees living and sharing their experiences all over the world. We are beyond excited about what we’re building, and believe our mission is just getting started.
Group Health Cooperative
Acquisition in 2015
Group Health Cooperative is a member-governed, non-profit healthcare organization that coordinates care and coverage. The organization offers health plans for individuals and families; state and federal employees; and employers such as small and large groups including employer-sponsored group plans. It also provides various specialty care services at its medical centers in contracted hospitals; and healthcare, pharmacy, and drug formulary services. In addition, Group Health Cooperative conducts non-proprietary public-interest research on preventing, diagnosing, and treating major health problems in the areas of aging and geriatrics, health services and economics, alternative approaches to healing, healthy communities, behavior change, medication use and patient safety, biostatistics, mental health, cancer, obesity, cardiovascular health, preventive medicine, child and adolescent health, vaccines and infectious diseases, chronic illness management, women’s health, and health informatics. Group Health Cooperative was founded in January 1947 and is based in Seattle, Washington with administrative offices in Tukwila, Bellingham, Spokane, Tacoma, and Kennewick, Washington.
Vapotherm
Series C in 2015
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients experiencing respiratory distress. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocities through a small-bore nasal interface. In addition to these systems, Vapotherm provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for air supply, and aerosol delivery accessories. The company aims to enhance clinical outcomes while improving patient comfort and compliance, and it primarily sells its products to hospitals through a direct sales organization in the United States and select international distributors. Founded in 1993, Vapotherm continues to focus on innovative solutions that enhance the quality of life for patients of all ages.
Vapotherm
Series C in 2015
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients experiencing respiratory distress. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocities through a small-bore nasal interface. In addition to these systems, Vapotherm provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for air supply, and aerosol delivery accessories. The company aims to enhance clinical outcomes while improving patient comfort and compliance, and it primarily sells its products to hospitals through a direct sales organization in the United States and select international distributors. Founded in 1993, Vapotherm continues to focus on innovative solutions that enhance the quality of life for patients of all ages.
Validic
Series B in 2015
Validic, Inc. is a technology company that provides a cloud-based platform for collecting and managing mobile health data from various Internet-enabled health applications and devices. Founded in 2010 and based in Durham, North Carolina, Validic connects healthcare providers with patient-recorded data through its solutions, including Validic Solution, Validic Connect, and Validic Mobile. The platform integrates data from over 400 clinical and consumer devices, enabling wellness companies, healthcare providers, pharmaceuticals, and health plans to access and utilize actionable health information. By streamlining the collection and visualization of personal health data, Validic aims to enhance the quality of care and improve health outcomes for individuals.
Health Catalyst
Series D in 2015
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
Bluesight
Series B in 2015
Bluesight addresses supply chain inefficiencies in healthcare by offering actionable analytics throughout the medication lifecycle. The company has developed a hospital inventory management platform that automates pharmacy kit processing and medication tracking, aiming to streamline the often cumbersome and error-prone manual processes associated with medication handling. By implementing automation technology, Bluesight enhances operational efficiency, improves patient safety, and increases medication visibility within hospitals. Through its suite of Medication Intelligence solutions, the company simplifies the complexities of medication management, providing healthcare professionals with the tools needed for better decision-making and risk reduction.
Ingenious Med
Venture Round in 2015
Ingenious Med, Inc. is a provider of cloud-based patient encounter and practice management systems tailored for the healthcare industry in the United States. Founded in 1999 and headquartered in Atlanta, Georgia, the company offers a comprehensive platform that includes tools for charge capture, care coordination, and advanced analytics. Its products, accessible through web and mobile applications, support inpatient physicians with functionalities such as digital communication, e-prescribing, and performance measurement. Ingenious Med's offerings also include coding and compliance tools, business intelligence tools, and back-office solutions that facilitate billing and coding processes. The company caters to a diverse clientele, including physician groups, academic institutions, healthcare systems, and management companies, and provides training and implementation services to enhance user adoption and effectiveness.
Ginger
Series B in 2014
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
MetricStream
Venture Round in 2014
MetricStream, Inc. specializes in governance, risk, and compliance software solutions, offering both cloud-based and on-premise options. The company's platform encompasses a variety of functions, including audit management, regulatory compliance, vendor governance, quality assurance, and risk management. By connecting these areas across an organization, MetricStream empowers clients to enhance business performance and make informed, risk-aware decisions. The company serves a diverse range of industries, including banking, healthcare, retail, and energy, providing tailored solutions to meet specific compliance and governance needs. Founded in 1999 and headquartered in Palo Alto, California, MetricStream has established a global presence with additional offices internationally and maintains a strategic alliance with Tech Mahindra Limited. Its comprehensive offerings also include implementation, training, and customer support services, catering to hundreds of thousands of users worldwide.
Valeritas
Series D in 2014
Valeritas Holdings, Inc. was a medical technology company focused on developing and commercializing innovative drug delivery solutions for patients with Type 2 diabetes. The company's primary product was the V-Go, a disposable insulin delivery device designed for continuous basal and on-demand bolus dosing, aimed at simplifying insulin management for users. Valeritas also worked on the V-Go Prefill, intended to streamline the device-filling process, and the V-Go SIM, which provided real-time tracking of insulin dosing. Founded in 2006 and headquartered in Bridgewater, New Jersey, Valeritas sold its products through third-party wholesalers and medical supply distributors. However, the company filed for Chapter 11 bankruptcy on June 30, 2020, ceasing operations.
Omada
Series B in 2014
Omada Health, Inc. is a digital healthcare company that creates and implements online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health focuses on helping employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the unique needs of participants, incorporating professional health coaching, connected health devices, and real-time data to foster sustainable lifestyle changes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program, delivering clinically effective solutions that empower individuals to take charge of their health and achieve their wellness goals.
Vapotherm
Series B in 2014
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat patients experiencing respiratory distress. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocities through a small-bore nasal interface. In addition to these systems, Vapotherm provides various companion products, such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for air supply, and aerosol delivery accessories. The company aims to enhance clinical outcomes while improving patient comfort and compliance, and it primarily sells its products to hospitals through a direct sales organization in the United States and select international distributors. Founded in 1993, Vapotherm continues to focus on innovative solutions that enhance the quality of life for patients of all ages.
Transcend Medical
Series C in 2014
Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70 million worldwide by the year 2015. In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial.
Health Catalyst
Series C in 2014
Health Catalyst is a technology company that specializes in data and analytics solutions for healthcare organizations. The company offers a platform that organizes, normalizes, and links health-related data from various systems, making it accessible and searchable for all users, including those without technical expertise. Health Catalyst operates through two main segments: the Technology segment, which generates the majority of its revenue through cloud-based subscriptions, time-based licenses, and maintenance fees for its data platforms and analytics applications; and the Professional Services segment, which provides a range of services including analytics, implementation, strategic advisory, and outsourcing to help clients optimize their use of the technology. By integrating and analyzing healthcare data, Health Catalyst aims to enhance decision-making and improve outcomes in the healthcare sector.
TriVascular
Series E in 2013
TRIVASCULAR is committed to developing new medical devices that address unmet clinical needs while providing an excellent working environment for its employees. The company was founded by Michael Chobotov, Ph.D., Robert Whirley, Ph.D., and Joseph Humphrey, Ph.D. TriVascular is located 50 miles north of San Francisco in the heart of the Sonoma Wine Country. TriVascular offers excellent career opportunities, benefits and quality of life to its employees. TRIVASCULAR's first products are next-generation transluminally placed endovascular grafts, often referred to as stent-grafts, for the treatment of aneurysmal disease in the abdominal aorta (AAA) and the thoracic aorta (TAA). Such endovascular procedures can lead to substantially lower mortality, morbidity, and cost compared to open surgical repair. TriVascular has developed a novel device design that achieves a low profile, permitting substantially improved access through the vasculature.
Xanitos
Venture Round in 2013
Xanitos, Inc. is a contracted environmental services provider specializing in hospital housekeeping, patient transportation, and central laundry services in the United States. Founded in 2008 and based in Newtown Square, Pennsylvania, the company offers comprehensive cleaning solutions for both patient and non-patient areas in acute healthcare facilities. Xanitos also provides linen and laundry management services, which include the development of usage policies, assessments of linen utilization, and logistics for clean linen distribution. The company's innovative XRO system enhances cleaning efficiency, while its focus on high-quality service aims to improve patient satisfaction and operational effectiveness. With a leadership team experienced in hospital services, Xanitos has demonstrated success in increasing cleaning quality, elevating patient experience scores, and reducing costs for the hospitals it serves.
Movable
Seed Round in 2013
Movable offers a wrist-worn activity monitor that measures all movement. Its product MOVband is a simple and fun wrist-worn activity monitor that measures all movement, not just steps. The company’s primary targets are corporate and school-based wellness programs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.